| Description |
1 online resource. |
| Physical Medium |
polychrome |
| Description |
text file |
| Series |
Pulmonary and respiratory diseases and disorders
|
|
Pulmonary and respiratory diseases and disorders series.
|
| Bibliography |
Includes bibliographical references and index. |
| Contents |
CYSTIC AND IDIOPATHIC PULMONARY FIBROSIS RISK FACTORS, MANAGEMENT AND LONG-TERM HEALTH OUTCOMES ; CYSTIC AND IDIOPATHIC PULMONARY FIBROSIS RISK FACTORS, MANAGEMENT AND LONG-TERM HEALTH OUTCOMES ; CONTENTS ; PREFACE; Chapter 1 CLINICAL MANIFESTATIONS OF CYSTIC FIBROSIS AND THEIR MANAGEMENT ; Abstract; List of Abbreviations; Introduction; Epidemiology; Molecular Biology; CFTR Gene; CFTR Biosynthesis; Structure of CFTR; Overview of CFTR Function; Pathophysiology; Types of Mutations; Class I Mutations; Class II Mutations; Class III Mutations; Class IV Mutations; Class V Mutations |
|
Class VI MutationsEffect of CFTR Dysfunction on Various Tissues; Sweat Glands; Lung and Small Airways; Paranasal Sinuses; Pancreas; Intestines; Liver and Gallbladder; Reproductive Tract; Bones; Other Organ Systems; Management; Clinical Features; Differential Diagnosis; Overview of Treatment; Treatment of Pulmonary Disease; Treatment of Gastrointestinal Disease; Treatment of Endocrine Abnormalities; Other Aspects of Treatment; Novel Treatment Strategies; Outcome Measures; Pulmonary Function Testing; Imaging-Based Measures; Sputum Biomarkers; Blood-Based Biomarkers; Potential Difference |
|
Sweat Chloride TestPrognosis and Risk Factors; Conclusion; Conflict of Interests; References; Biographical Sketch; Chapter 2 LIVER DISEASE IN CYSTIC FIBROSIS: PREVALENCE, RISK FACTORS, AND OUTCOMES ; Abstract; Introduction; Objective; Methods; Screening for Liver Disease; Physical Examination; Liver Biochemistry Studies; Echographic Examination; Hepatobiliary Scintigraphy; Analysis of Clinical and CFTR Genotype Data; Statistic Analysis; Results; Discussion; Conclusion; References; Chapter 3 LUNG TRANSPLANTATION FOR CYSTIC FIBROSIS ; Abstract; Introduction |
|
Selection of Patients for Lung TransplantationCriteria for Referral; Contraindications; Pre-Transplant Evaluation; Listing for Transplantation; Preparation for Transplantation; Surgical Issues and Technical Considerations; Post-Transplant Management; Peri-Operative Management and Complications; Delayed Onset and Chronic Complications; Post-Transplant Surveillance; Outcomes; Conclusion; References; Chapter 4 NEW CYSTIC FIBROSIS THERAPY ; Abstract; Introduction; Evolution of CF Therapy; Nutritional Management; Clinical Trials of Ivacaftor in Patients with the Gly551Asp CFTR Mutation |
|
Clinical Trials of Ivacaftor in Patients with CFTR Mutation Other Than G551DTargeted Therapies for Patients with Phe508del CFTR Mutation; Targeted Therapies for Patients with Class I Mutation; Gene Therapy; Conclusion; References; Biographical Sketch; Chapter 5 DISTINCT PATTERNS OF PULMONARY INJURY AND FIBROSIS INDUCED BY INTRATRACHEAL AND SUBCUTANEOUS BLEOMYCIN IN THE MOUSE: RELEVANCE FOR DISTINCT FORMS OF HUMAN LUNG FIBROSIS ; Abstract; List of Abbreviations; Introduction; Results |
| Local Note |
eBooks on EBSCOhost EBSCO eBook Subscription Academic Collection - North America |
| Subject |
Cystic fibrosis.
|
|
Cystic fibrosis. |
| Genre/Form |
Electronic books.
|
|
Electronic books.
|
| Added Author |
Robertson, Lorenzo, editor.
|
| Other Form: |
Print version: Robertson, Lorenzo Cystic and Idiopathic Pulmonary Fibrosis: Risk Factors, Management and Long-Term Health Outcomes Hauppauge : Nova Science Publishers, Inc.,c2016 9781634855082 |
| ISBN |
9781634855488 (electronic book) |
|
1634855485 (electronic book) |
|
9781634855082 |
|
1634855086 |
|
